Dabigatran Etexilate Mesylate: Your Advanced Anticoagulant Solution
Discover the future of blood clot prevention and stroke reduction with our high-purity Dabigatran Etexilate Mesylate.
Get a Quote & SampleProduct Core Value
Dabigatran Etexilate Mesylate
As a leading pharmaceutical intermediate, Dabigatran Etexilate Mesylate (CAS 872728-81-9) is a vital component in modern anticoagulation therapy. Its primary function is to inhibit thrombin, a key factor in blood clot formation, thereby offering a direct and effective pathway to manage thrombotic risks.
- Explore the benefits of using Dabigatran Etexilate Mesylate as an oral anticoagulant to prevent strokes in patients with atrial fibrillation.
- Learn how this pharmaceutical intermediate is crucial for treating blood clots like DVT and PE, ensuring better patient outcomes.
- Discover the application of Dabigatran Etexilate Mesylate in anticoagulant therapy post hip replacement, minimizing post-operative complications.
- Understand the high purity (>99%) and solid powder form, ensuring consistent quality for your formulations.
Key Advantages Offered
Direct Thrombin Inhibition
Leverage the power of direct thrombin inhibition to effectively manage blood coagulation, a critical aspect when considering oral anticoagulant therapy.
Reduced Stroke Risk
Significantly lower the chance of stroke for individuals with atrial fibrillation by incorporating this advanced anticoagulant.
Broad Therapeutic Use
Utilize this versatile intermediate for treating deep vein thrombosis (DVT) and pulmonary embolism (PE), covering essential cardiovascular needs.
Key Applications
Stroke Prevention
A primary use of Dabigatran Etexilate Mesylate is in preventing strokes, especially for patients diagnosed with atrial fibrillation.
DVT and PE Treatment
Effectively treat conditions like deep vein thrombosis and pulmonary embolism, safeguarding circulatory health.
Post-Surgical Care
Administered to prevent blood clots after orthopedic surgeries such as hip replacements.
Pharmaceutical Manufacturing
As a high-quality intermediate, it is essential for the production of finished anticoagulant medications.